Billions Charged to Pharma Over Fraud on Government
Written By: Rheingold, Giuffra, Ruffo & Plotkin LLP
According to a new study by Public Citizen pharmaceutical companies have been fined is $19.8 billion over the past 20 years coming from the False Claims Act. Of that $19.8 Billion, $14.8 has been in the last 5 years and $10.5 billion in fines went to just 4 drug companies, Merck's Schering-Plough, GlaxoSmithKline, Pfizer, and Eli Lilly.
The most common violations were for overcharging Medicaid, but other charges included illegal promotion of a drug, anti-trust violations, Kick-backs, concealing clinical trial findings, poor manufacturing practices, among others.
Unfortunately fraud charges like these can result in patients getting hurt. The lawyers at Rheingold, Giuffra, Ruffo & Plotkin LLP represent their client's interests in recovering damages brought about from off label marketing, concealing trial findings, and other dangerous practices by Pharma. Contact the New York Attorneys at Rheingold, Giuffra, Ruffo & Plotkin LLP to speak with an experiences product liability professional.